CLOV seems to be in a great buying opportunity. Chammath is in this company and from doing my research he is part of the board of directors of this company. He came out on CNBC talking about this company. RSI is oversold territory which is undervalued.
Great revenue growth + growth potential with Biden administration too, hot IPO, hot supporters, lots of social media attention to cause short term demand imbalance
$CLOV is a health Tech company that is targeting to disrupt the traditional insurance companies. It targets to provide lower health care costs to seniors using medicare plans and provides cheaper coverage and reducing costs by 20%. This is a recent SPAC merger from chamath's famous IPOC (Social Capital Hedosophia Holdings).
Its merger was approver & it started...
